Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-22

Clinical Trial Update: Dexmedetomidine After Cardiac Surgery for Prevention of Delirium [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexmedetomidine after cardiac surgery for prevention of ICU delirium has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University Hospital, Brest | Conditions: ICU Delirium | Phase 3 | Status: COMPLETED